Aim. To study perfusion and metabolism of LV myocardium in patients with dilated cardiomyopathy (DCMP) and to invent on this basement a gamma-specific predictors for cardio-resynchronizing therapy (RT) efficacy. Material and methods. Totally 63 patients with DCMP included (41 male, 22 female) with mean age 55,4±8,3 y.o., having congestive heart failure (CHF) of III-IV NYHA. Before RT all patients underwent scintigraphy of myocardium with "Т (for perfusion assessment) and 123I (for fatty acids metabolism). Before and in 6 months after RT all patients underwent echocardiography to assess intracardiac hemodynamics.Results. In 6 months after RT all patients were divided into two groups: 1) EDV LV decreased by >15% (n= 39) — "responders", and 2) ESV LV decreased <15% (n=24) — "non-responders". Before RT groups did not significantly differ by pumping function of the ventricle. Significant difference was found by following pre-operational scintigraphic parameters: perfusion defect (PD) (9,22±5,06% and 12,5±4,22%, p<0,01), metabolism defect on earlier pictures (MD) (9,21±5,42% and 11,27±5,39%, p<0,01). The equation of multiple regression was invented, which may prognose the dynamics of end-systolic volume after RT.By the ROC analysis data the main prognostic significance for RT has the size of metabolism defect area and calculated value of end-systolic volume dynamics. The best threshold MD=7,35% and it confirms the efficacy of RT with 77,8% sensitivity and 66,7% specificity. The best threshold value of calculated end- systolic volume dynamics — 34,02 confirms the 87,5% sensitivity and 100% specificity of RT.Conclusion. The data collected during metabolic myocardial gamma-scintigraphy may be used in the complex of methods that allow to predict the efficacy of cardio- resynchronizing therapy.
1. Manolio T, Baughman K, Rodeheffer R, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol 1992; 69:1458-66.
2. Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation. 2003; 108:2596-603.
3. Bax JJ, Abraham T, Barold SS, et al. Cardiac Resynchronization Therapy. JACC. 2005; 46 (12):2168-82.
4. Sokolov AA, Marcinkevich GI. Electromechanical asynchrony and heart failure. Cardiology journal 2005; 45 (5):85-91. Russian (Соколов А. А., Марцинкевич Г. И. Электромехан ический асинхронизм сердца и сердечная недостаточность. Кардиология 2005; 45 (5):85-91).
5. Popov SV, Savenkova GM, Antonchenko IV. Effects of cardiac resynchronization therapy in the treatment of congestive heart failure. Siberian Journal of Medical (Tomsk city) 2010; 25 (2-1):25-33. Russian (Попов С. В., Савенкова Г.М., Антонченко И. В. и др. Эффекты кардиоресинхронизирующей терапии в лечении застойной сердечной недостаточ¬ности. Сибирский медицинский журнал (г. Томск). 2010; 25 (2-1):25-33).
6. Anagnostopoulos CD, Cokkinos DV. Prediction of left ventricular remodeling by radionuclide imaging. Eur J Nucl Med Mol Imaging 2011; 38 (6):1120-3.
7. Lishmanov Y Minin S, Efimova I, et al The possible role of nuclear imaging in assessment of the cardiac resynchronization therapy effectiveness in patients with moderate heart failure. Ann Nucl Med. 2013 27 (4):378-85.
8. Hesse B, T gil K, Cuocolo A, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging. 2005; Jul; 32 (7):855-97.
9. Ryzhkova DV, Tjutin LA, Mostova MI, et al. Positron emission tomography in the differential diagnosis of heart cardiomegaly coronary and noncoronary origin. Arterial hypertension 2009; 15 (2):227-32. Russian (Рыжкова Д. В., Тютин Л. А., Мостова М. И. идр. Позитронная эмиссионная томография сердца в дифференциальной диагностике кардиомегалии ишемической и некоронарогенной природы. Артериальная гипер- тензия 2009; 15 (2):227-32).
10. Taki J, Nakajima K, Matsunari I, et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med. 1997; 38 (10):1503-10.
11. Hassan N, Escanye JM, Juilliere Y et al. 201Tl SPECT abnormalities, documented at rest in dilated cardiomyopathy, are related to a lower than normal myocardial thickness but not to an excess in myocardial wall stress. J Nucl Med. 2002; 43 (4):451-7.
12. Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008; 117 (20):2608-16.
13. Tanaka H, Nesser HJ, Buck T. Dyssynchrony by speckle-trackingechocardiography and response to cardiac resynchronization therapy: resultsof the Speckle Tracking and Resynchronization (STAR) study. Eur Heart J2010; 31:1690-700.
14. Birnie D, de Kemp RA, Tang AS, et al. Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy. J NuclCardiol. 2012; 19 (1):73-83.
15. Lehner S, Uebleis C, SchdBler F, et al. The amount of viable and dyssynchronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gatedFDG PET. Eur J Nucl Med Mol Imaging. 2013; 40 (12):1876-83.
